Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pulm Pharm > Autonomic Drugs > Flashcards

Autonomic Drugs Flashcards

1
Q

Muscarinic receptors in the lung

A

-M2 = Gαi = decreased cAMP, increase K+ channel opening
i. Inhibitory receptor controlling the release of Ach
ii. Asthma = activated eosinophils release major basic protein, which binds to M2 receptors and prevents binding of acetylcholine. Thus, the normal negative feedback control of acetylcholine release is lost, and acetylcholine release is increased. In conclusion, loss of function of inhibitory M2 muscarinic receptors on the airway parasympathetic nerves causes vagally mediated
bronchoconstriction and hyperresponsiveness following antigen challenge
-M3= Gαq = PLC activation = inc IP3/DAG = inc [Ca]i
i. Bronchial smooth muscle contraction
ii. Mucus gland activation
2. **net effect of cholinergic agonists will be bronchoconstriction and inc mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acetylcholine

A
  • At minimal doses causes vasodilation and reflex tachycardia. At larger doses causes bradycardia, dec. AV nodal conduction celocity, and hypotension.
  • Causes bronchoconstricion and inc. bronchial secretions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bethanechol

A
  • MOA-Activates muscarinic (M) receptors–>increases IP3 and DAG
  • May cause bronchoconstriction and inc. bronchial secretions
  • Oral, IM activity Poor lipid solubility: does not enter CNS
  • Duration: 0.3–2 h
  • Tox-All parasympathomimetic effects: cyclospasm, diarrhea, urinary urgency, plus vasodilation, reflex tachycardia, and sweating.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pilocarpine

A

MOA-Activates muscarinic (M) receptors–>increases IP3 and DAG, may also activate EPSP via M receptors in ganglia

  • May cause bronchoconstriction and inc. bronchial secretions
  • Oral, IM activity
  • Tox-Similar to bethanechol but may cause vasoconstriction via ganglionic effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Muscarine

A

MOA-Activates muscarinic (M) receptors–>increases IP3 and DAG, may also activate EPSP via M receptors in ganglia

  • May cause bronchoconstriction and inc. bronchial secretions
  • No CNS effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nicotine

A
  • MOA-Activates all nicotinic (N) receptors, opens Na+-K+ channels in ganglia and neuromuscular end plates
  • Use-smoking cessation (also used as insecticide)
  • High lipid solubility, absorbed by all routes
  • Duration: 4–6 h
  • Tox-Generalized ganglionic stimulation: hypertension, tachycardia, nausea, vomiting, diarrhea Major overdose: convulsions, paralysis, coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nicotinic ganglionic blockers

A
  • hexamethonium, trimethaphan, mecamyline
  • MOA-Selective block of Nn receptors
  • Obsolete; was used for hypertension
  • Oral, parenteral Block of all autonomic effects
  • Trimethaphan: IV only, short-acting; was used for hypertensive emergencies and controlled hypotension
  • mecamylamine: oral, enters CNS; investigational use for smoking cessation
  • Tox: dec. arteriolar and venomotar tone–>hypotension. Also dec. contractility and moderate tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Echothiophate

A
  • MOA-irreversibly binds AchE and slowly phosphorylates the active site of AchE very slowly=extremely stable
  • Can undergo agin
  • ->bronchoconstriction & inc. bronchial secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Physostigmine

A
  • MOA-Inhibitor of cholinesterase, amplifier of endogenously released
  • Use-Reversal of severe atropine poisoning (IV), occasionally used in acute glaucoma (topical)
  • Lipid soluble, can be used topically in the eye
  • Duration: 2–4 h
  • Tox-Increased parasympathetic effects, especially nausea, vomiting, diarrhea, urinary urgency, CNS effects: seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Edrophonium

A

-MOA-Inhibitor of cholinesterase, amplifier of endogenously released ACh
-Use-Reversal of NM block by nondepolarizing
drugs
-used IV, Duration: 5–10 min
-Tox-Increased parasympathetic effects, especially nausea, vomiting, diarrhea, urinary urgency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atropine, ipatropium, tiotropium, scopolamine

A

-MOA-Competitive pharmacologic antagonist at all
M receptors
-Uses-Useful in COPD where blockade of postganglionic parasypathetic M2 receptors can help to eliminate bronchodilation
-Lipid-soluble, Duration: 2–4 h, except in eye: ≥72 h
-Tox-All parasympatholytic effects plus sedation, delirium,
hyperthermia, flushing
-Ipratropium, tiotropium: inhaled for asthma, chronic obstructive pulmonary disease
-Scopolamine: anti-motion sickness via transdermal patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Epinephrine

A

-MOA-α1, α2, β1, β2, β3 agonist
-Uses Anaphylaxis, hemostatic cardiac arrest
-Parenteral and topical only, does not enter CNS, Duration: short
-Tox-Hypertension, arrhythmia, stroke, myocardial
infarction, pulmonary edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Norepinephrine

A

MOA-α1, α2, β1 agonist
-Uses-Shock, hypotension
-IV only Vasospasm
Tox-tissue necrosis, excessive blood pressure increase, arrhythmias, infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Albuterol, Terbutaline, Metaproterenol, Salmeterol

A
  • MOA-β2 agonist
  • Uses-Prompt onset for acute bronchospasm
  • Inhalant via aerosol canister, Duration: 2–6 h
  • Tox-Tachycardia, tremor
  • Salmeterol-β2 agonists; slow onset, long action. Not useful in acute bronchospasm, used only with corticosteroids for prophylaxis of asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tyramine

A

-MOA-Displaces stored catecholamines
-No clinical use but found in fermented foods
-Normally high first-pass effect, but in patients
taking MAO inhibitors it is absorbed
-Tox-Hypertension, arrhythmias, stroke, myocardial
infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reserpine

A
  • MOA-Drug that inhibits VMAT, transporter of dopamine and norepinephrine into transmitter vesicles of adrenergic nerves
  • ->dec. cardiac ouput and dec. peripheral vascular resistance
  • Tox-at high doses this can cause sedation, mental depression, parkinsonism symptoms, CI w/ depression
17
Q

Guanadrel

A
  • MOA-blocks reuptake of norepinephrine (NET) and depletes stores
  • oral, long duration
  • Tox-severe orthostatic hypotension
18
Q

Ephedrine, psuedoephedrine

A

-MOA-Releases stored catecholamines, causes
nonselective sympathetic effects
-Use-Asthma (obsolete)
-Oral, Duration: 6–8 h
-Tox-Insomnia, tremor, anorexia, arrhythmias
-psuedoephedrine is just an enantiomer

19
Q

Cocaine

A

-MOA-Blockade of Na+ channels slows, then prevents axon potential propagation, cocaine has intrinsic
sympathomimetic actions
-Rapid metabolism via plasma esterases, short half-lives
-Uses-Analgesia, topical
-Tox-CNS: excitation, seizures CV: vasodilation, hypotension, arrhythmias (bupivacaine)As above re CNS actions, cocaine vasoconstricts. When abused has caused hypertension and cardiac arrhythmias

20
Q

Amphetamine

A

-Sympathomimetic drug that facilitates the release of catecholamines from adrenergic nerve endings

21
Q

Prazosin, terazosin, tamsulosin

A
  • MOA-Competitive antagonism at α1 receptors
  • Uses-Nasal Decongestion, Hypertension, benign prostatic hyperplasia
  • Oral, Duration: 8 h
  • Tox-Orthostatic hypotension (especially first dose), but little reflex tachycardia
  • terazosin: like prazosin; longer duration of action (12–24 h)
  • Tamsulosin: like prazosin, approved only for benign prostatic hyperplasia
22
Q

phenoxybenzamine

A

-MOA-alpha blocker-Irreversible (covalent) binding
to α receptors
-Uses-Pheochromocytoma, carcinoid, mastocytosis,
Raynaud’s phenomenon
-Oral, short half-life but long duration of action (24–48 h)
-Tox-Orthostatic hypotension, reflex tachycardia, gastrointestinal irritation

23
Q

Phentolamine

A

-MOA-Competitive pharmacologic antagonism at α receptors
-Uses-Pheochromocytoma, antidote to overdose
of α agonists
-Oral, IV, short half-life, Duration: 2–4 h
-Tox-Orthostatic hypotension, reflex tachycardia

24
Q

Labetalol

A

-MOA-Four isomers; 2 bind and block both α and β receptors, alpha1 selective, equally inhibits beta receptors
-Uses-Hypertension, hypertensive emergencies (IV)
-Oral and IV, Duration: 5 h
-Tox-Excessive β blockade: bronchospasm (can be fatal in asthmatics), atrioventricular block, heart failure, CNS
sedation, lethargy, sleep disturbances

25
Q

Atenolol, Metoprolol, Esmolol

A

-Competitive block of β1 receptors
-Uses-Hypertension especially useful in HTN tx in asthmatics, angina, arrhythmias
-Oral, Duration: 6–9 h
-Tox-Excessive β blockade: bronchospasm (can be fatal in asthmatics), atrioventricular block, heart failure, CNS
sedation, lethargy, sleep disturbances
-Esmolol: IV agent for perioperative and thyroid storm arrhythmias, hypertensive emergency
-Metoprolol: like atenolol, oral, shown to reduce mortality in heart failure

26
Q

Propanolol, Pindolol

A

-MOA-Competitive block of β receptors, local anesthetic
effect
-Uses-Angina, arrhythmias (treatment and prophylaxis),
hypertension, thyrotoxicosis, tremor, stage fright, migraine
-Oral and IV, Duration: 4–6 h. Ready entry into CNS
Excessive β blockade:
-Tox-C/I in asthma pts(bronchoconstriction) bronchospasm (can be fatal in asthmatics), atrioventricular block, heart failure, CNS sedation, lethargy, sleep disturbances
-Pindolol: partial agonist action; possibly safer in asthma

27
Q

hexamethonium, trimethaphan, mecamyline

A

Nicotinic ganglionic blockers

Pulm Pharm (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions